Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedMar 27, 2019Morphine Sulfate 30 mg/30 mLLack of Assurance of SterilityAdvanced Pharma Inc. · D-1033-2019Class IITerminatedMar 27, 2019Phenylephrine HClLack of Assurance of SterilityAdvanced Pharma Inc. · D-1032-2019Class IITerminatedMar 27, 2019Heparin 5Lack of Assurance of SterilityAdvanced Pharma Inc. · D-1031-2019Class IITerminatedMar 27, 2019Heparin 10 Units/10 mL 10 Units in 0.45% Sodium ChlorideLack of Assurance of SterilityAdvanced Pharma Inc. · D-1030-2019Class IITerminatedMar 27, 2019Esmolol HCl Injectable Solution 100 mg/10 mLLack of Assurance of SterilityAdvanced Pharma Inc. · D-1029-2019Class IITerminatedMar 27, 2019Phenylephrine HClLack of Assurance of SterilityAdvanced Pharma Inc. · D-1028-2019Class IITerminatedMar 27, 20192% Lidocaine HCl Injectable SolutionLack of Assurance of SterilityAdvanced Pharma Inc. · D-1027-2019Class IITerminatedMar 27, 20192% Lidocaine HCl Injectable SolutionLack of Assurance of SterilityAdvanced Pharma Inc. · D-1026-2019Class IITerminatedMar 27, 2019Glycopyrrolate 0.6 mg/3 mLLack of Assurance of SterilityAdvanced Pharma Inc. · D-1025-2019Class IITerminatedMar 27, 2019Neostigmine Methylsulfate Injection Solution 5 mg/5mLLack of Assurance of SterilityAdvanced Pharma Inc. · D-1024-2019Class IITerminatedMar 27, 2019Phenylephrine HClLack of Assurance of SterilityAdvanced Pharma Inc. · D-1023-2019Class IITerminatedMar 27, 2019Phenylephrine HClLack of Assurance of SterilityAdvanced Pharma Inc. · D-1022-2019Class IITerminatedMar 27, 2019Glycopyrrolate Injectable Solution 1 mg/5 mLLack of Assurance of SterilityAdvanced Pharma Inc. · D-1021-2019Class IITerminatedMar 27, 2019Phenylephrine HClLack of Assurance of SterilityAdvanced Pharma Inc. · D-1020-2019Class IITerminatedMar 27, 2019Midazolam Benzodiazepine 50 mg/50 mLLack of Assurance of SterilityAdvanced Pharma Inc. · D-1019-2019Class IITerminatedMar 27, 2019fentaNYL 2500 mcg/250 mL Injectable SolutionLack of Assurance of SterilityAdvanced Pharma Inc. · D-1018-2019Class IITerminatedMar 27, 2019fentaNYL 1000 mcg/100 mL Injectable Solution Fentanyl 0.9% Sodium ChlorideLack of Assurance of SterilityAdvanced Pharma Inc. · D-1017-2019Class IITerminatedMar 27, 2019HYDROmorphone HCl 1 mg in 0.9% Sodium ChlorideLack of Assurance of SterilityAdvanced Pharma Inc. · D-1016-2019Class IITerminatedMar 27, 2019Alprazolam TabletsFailed Impurities/Degradation Specifications: Elevated levels of a known impurity detected during 6-month RT stability interval.Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · D-1013-2019Class IITerminatedMar 27, 2019Hydrocortisone and Acetic Acid Otic SolutionSub Potent Drug: OOS results observed for the Hydrocortisone assay during routine stability testing at 12 month controlled room temperature.Akorn Inc · D-1011-2019Class IIITerminatedMar 27, 2019Testosterone Topical SolutionDefective Container: Repetitive complaints received indicating pump not working.Lupin Pharmaceuticals Inc. · D-1010-2019Class IITerminatedMar 27, 2019VolumexLack of Assurance of Sterility: preliminary environmental monitoring report exceeds limits, therefore sterility cannot be assured.Iso-Tex Diagnostics, Inc · D-1008-2019Class IITerminatedMar 27, 2019Docusate SodiumLabeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.Rx Pak Division of McKesson Corporation · D-1007-2019Class IIITerminatedMar 27, 2019Lansoprazole Delayed-Release Orally Disintegrating TabletsSubpotent Drug.Teva Pharmaceuticals USA · D-1006-2019Class ITerminatedMar 20, 2019Levoleucovorin InjectionPresence of Particulate Matter: particulate matter identified as copper saltsMylan Institutional Inc · D-1059-2019Class IITerminatedMar 20, 2019Little Remedies New Baby Essentials Kit. Each kit contains 1 each of the following products: Little Remedies...Incorrect/undeclared excipients: Kit carton bear incorrect labeling for two of the five items contained within the kit.Medtech Products, Inc. · D-1012-2019Class ITerminatedMar 20, 2019Golean DETOX capsulesMarketed Without an Approved NDA/ANDA: FDA analysis found product to contain undeclared sibutramine and phenolphthalein. Sibutramine is an appetite suppressant that was...Golean Detox US · D-1009-2019Class IITerminatedMar 20, 2019Telmisartan and Hyrdochlorothiazide Tablets 80 mg/25 mgFailed Content Uniformity Specifications: The product is out of specification for blend uniformity.Macleods Pharma Usa Inc · D-1005-2019Class IITerminatedMar 20, 2019Telmisartan and Hyrdochlorothiazide TabletsFailed Content Uniformity Specifications: The product is out of specification for blend uniformity.Macleods Pharma Usa Inc · D-1004-2019Class IITerminatedMar 20, 2019Telmisartan and Hyrdochlorothiazide Tablets 40mg/12.5 mgFailed Content Uniformity Specifications: The product is out of specification for blend uniformity.Macleods Pharma Usa Inc · D-1003-2019Class IITerminatedMar 20, 2019Oxygen, Refrigerated Liquid USPCGMP DeviationsRoberts Home Medical LLC · D-1002-2019Class IITerminatedMar 20, 2019Docetaxel Injection USPDefective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance.Dr. Reddy's Laboratories, Inc. · D-1001-2019Class IIITerminatedMar 20, 2019Oxybutynin ChlorideFailed Dissolution SpecificationsLannett Company Inc. · D-0996-2019Class IITerminatedMar 20, 2019Gentamicin Sulfate Ophthalmic SolutionFailed Impurities/Degradation Specifications: High Out-of-Specification (OOS) results for Individual and Total Impurities that have been identified at the 18 months...Akorn, Inc. · D-0993-2019Class IIITerminatedMar 20, 2019MirapexFailed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.Boehringer Ingelheim Pharmaceuticals, Inc. · D-0991-2019Class IIITerminatedMar 20, 2019Oxybutynin Chloride Extended-Release Tablets USP 10 mgFailed Dissolution SpecificationsAVKARE Inc. · D-0990-2019Class ITerminatedMar 20, 2019Dr. King's SafeCare Rx Breast Cyst & Discomforts High Potency Homeopathic Formula for Professional Use OnlyMicrobial contaminationKing Bio Inc. · D-0985-2019Class ITerminatedMar 20, 2019Dr. King's SafeCare Rx Aversion to Change High Potency Homeopathic Formula for Professional Use OnlyMicrobial contaminationKing Bio Inc. · D-0984-2019Class ITerminatedMar 20, 2019Dr. King's Natural Medicine Regional Allergies Hawaii U.S. HomeopathicMicrobial contaminationKing Bio Inc. · D-0983-2019Class ITerminatedMar 20, 2019Dr. King's Natural Medicine Leg Cramp & Spasm Relief HomeopathicMicrobial contaminationKing Bio Inc. · D-0982-2019

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.